Primary pleomorphic adenomas in the middle ear and external auditory canal (EAC) are rare. They have three possible sources: ceruminous glands, ectopic salivary tissue, or mucosal epithelium. [1] [2] [3] [4] Metastases to the temporal bone travel from the parotid to the middle ear and mastoid, 5 and residual parotid pleomorphic adenomas can extend superiorly through the stylomastoid foramen along the facial nerve.
Primary pleomorphic adenomas in the middle ear and external auditory canal (EAC) are rare. They have three possible sources: ceruminous glands, ectopic salivary tissue, or mucosal epithelium. [1] [2] [3] [4] Metastases to the temporal bone travel from the parotid to the middle ear and mastoid, 5 and residual parotid pleomorphic adenomas can extend superiorly through the stylomastoid foramen along the facial nerve. 6, 7 These distant and regional metastases can have either benign 5, 6 or malignant 7 histology.
This report of pleomorphic adenoma of the middle ear and mastoid, arising independent of any parotid mass, is meant to increase awareness of this tumor as a primary temporal bone tumor. In addition, as this case demonstrates, these primary temporal bone pleomorphic adenomas tend to recur and to be aggressive.
A 43-year-old woman presented to our otolaryngology center 5 years after a left basic mastoidectomy. She was unaware of the diagnosis from this operation, and her subjective hearing loss had not improved postsurgical- ly. On presentation, she had had 1 year of left ear bleeding, progressive left facial weakness, and a mass in her previous incision line.
On physical examination, a fleshy growth was found to be occluding the entire EAC, and a subcutaneous and i l l-def ined mass was centered on her postauricular scar. Her facial motion showed III/VI on the House-Brackmann scale. No other parotid or neck masses were palpated. The patient's pure-tone average was 58 dB, entirely conductive. Computed tomography (CT) showed partial absence of the mastoid cortex and soft tissue filling all available air cell spaces and eroding natural septations (figure 1). No masses in either parotid gland were noted on CT. Biopsy of the postauricular mass revealed pleomorphic adenoma.
The patient underwent left canal-wall-down mastoidectomy; the EAC was closed with a temporalis muscle rotational flap. Tumor was found to be filling the entire middle ear space, canal, and mastoid (figure 2). The facial nerve in the epitympanum was directly covered with tumor. There was no tumor expansion into or from the adjacent parotid, either near the mastoid tip or near the tragal/glenoid fossa area. Nor was there any extension of tumor beyond the limits of the mastoid and tympanic ring; the glenoid fossa, tegmen, mastoid tip, and medial wall of the epitympanum were all intact.
Subsequent pathologic diagnosis was adenocarcinoma. Therefore, this individual's tumor was a carcinoma ex pleomorphic adenoma, primary in the temporal bone.
Pleomorphic adenoma, a neoplasm of salivary tissue, is rarely seen in the ear canal, middle ear, and mastoid. Reiland et al tallied 45 reports of metastasizing pleomorphic adenoma, each listing 1 to 12 cases, with metastases to the alveolus, turbinate, temporal bone, and infratemporal fossa. 5 The reports differed from ours in that all the metastases arose from the parotid and were histologically benign.
Others report direct extension of pleomorphic adenomas from the parotid along the entire intratemporal facial nerve. 6, 7 In these cases, the original tumor was in the parotid, and physical progress of the tumor was by direct extension through the stylomastoid foramen along the entire nerve canal. In contrast to these metastatic cases, primary pleomorphic adenomas in the EAC, middle ear, or mastoid have been speculated to arise in the ceruminous glands of the EAC, ectopic salivary gland tissue, or middle ear mucosal metaplasia. [1] [2] [3] [4] Also unlike the metastatic cases, primary pleomorphic adenomas tend to recur and tend to be aggressive. Our case did both: recurring after the previous resection, causing facial weakness and being confirmed as carcinoma ex pleomorphic adenoma.
